Focus 1: Yingfang Micro - The company is planning a major asset restructuring by acquiring controlling stakes in Shanghai Xiaokeli Information Technology Co., Ltd., FIRST TECHNOLOGY CHINA LIMITED, and Shiqing Intelligent Technology (Shanghai) Co., Ltd. through a combination of share issuance and cash payment [1] - The transaction is expected to constitute a significant asset restructuring but will not involve related transactions or restructuring listings. The company's stock will be suspended from trading starting January 6, 2026 [1] Focus 2: Nanxing Co. and Yinglian Co. - Nanxing Co. expects to achieve a net profit of 90 million to 120 million yuan for 2025, recovering from a loss of 175 million yuan in the previous year. The significant profit increase is attributed to reduced goodwill impairment in 2024 [2] - Yinglian Co. anticipates a net profit of 32 million to 42 million yuan for 2025, compared to a loss of approximately 39.67 million yuan in the previous year, driven by growth in the fast-moving consumer goods metal packaging sector [2] Focus 3: Victory Energy - The company has completed its stock trading suspension review and will resume trading on January 6, 2026. No undisclosed significant information affecting stock prices was found during the review [3] Performance Highlights - Whirlpool expects a net profit of approximately 505 million yuan for 2025, a 150% increase from the previous year, due to ongoing transformation and efficiency improvements [4] - Taotao Automotive forecasts a net profit of 800 million to 850 million yuan for 2025, representing an 85.5% to 97.1% increase year-on-year, driven by enhanced operational efficiency and market demand [4] - China National Materials Technology anticipates a net profit of 1.55 billion to 1.95 billion yuan for 2025, a growth of 73.79% to 118.64% compared to the previous year, supported by improved product pricing and sales [4] Investment and Restructuring - Weigao Blood Products plans to issue shares to acquire 100% of Weigao Group Medical Polymer Co., Ltd. for 8.511 billion yuan, significantly enhancing the company's asset scale and profitability [6] - Haopeng Technology is set to raise up to 800 million yuan through a private placement to fund energy storage battery projects [6] Control Changes - Hengshi Technology's control has changed following agreements with New Base Information Technology Group, with the new controlling entity holding 9.55% of the total shares [7] Major Projects - Fulian Precision plans to invest 6 billion yuan in a project to produce 500,000 tons of high-end lithium iron phosphate for energy storage [10] - Penghui Energy's board approved plans to issue H-shares and list on the Hong Kong Stock Exchange [11] Other Announcements - The company intends to repurchase A-shares for employee stock ownership plans, with a total budget of 50 million to 100 million yuan [12] - The company reported a 14.75% year-on-year decline in pig sales, with a revenue drop of 36.06% due to market fluctuations [12]

Core Viewpoint - The announcement from Zaiseng Technology (再升科技) regarding the termination of the share transfer agreement with Zhongrong Huaxin International Biotechnology (中融华信) raises questions about the underlying reasons for this abrupt decision, which occurred just 28 days after the initial agreement was signed [2][3]. Group 1: Share Transfer Agreement - On December 8, 2025, Zaiseng Technology's controlling shareholder, Guo Mao, signed a share transfer agreement to sell 6.04% of the company's shares to Zhongrong Huaxin for a total of 344 million yuan, at a price of 5.53 yuan per share [2][3]. - The agreement was seen as a strategic move to optimize the company's equity structure and introduce external capital [3]. - The termination of the agreement was attributed to "changes in objective circumstances," although specific details were not disclosed [3][4]. Group 2: Financial Performance - Zaiseng Technology reported a 10.11% year-on-year decline in revenue for the first three quarters of 2025, totaling 985 million yuan, and a 10.59% decrease in net profit to 81.25 million yuan [5]. - Despite the overall decline, the company achieved a significant quarterly net profit increase of 42.42% in Q3 2025, amounting to 20.97 million yuan, driven by cost reduction and new product development [5]. - The company's cash flow situation improved markedly, with net cash flow from operating activities reaching 260 million yuan, a 60.51% increase year-on-year [5].

Group 1 - Victory Energy announced that its stock price increased by 213.97% from December 12 to December 29, 2025, leading to a review of trading fluctuations, with stock resuming trading on January 6, 2026 [2] - Tianqi Materials plans to conduct maintenance on its 150,000-ton liquid lithium hexafluorophosphate production line for 20 to 30 days, ensuring no significant impact on operations [3] - Yingfang Micro is planning to acquire controlling stakes in several companies, leading to a significant asset restructuring, with stock suspension starting January 6, 2026 [4] Group 2 - Weigao Blood Purification intends to acquire 100% of Weigao Purui for 8.511 billion yuan, which will enhance its product offerings in medical packaging [6] - Zhongtian Rocket reported losses in its carbon/carbon thermal field materials business due to intensified competition in the photovoltaic industry, significantly impacting its consolidated financial statements [7] - Fulin Precision plans to invest 6 billion yuan in a project to produce 500,000 tons of high-end lithium iron phosphate for energy storage, alongside additional projects for precursor materials [8] Group 3 - Deyun Co. announced that its actual controller was arrested for illegal public deposit collection, but this will not significantly affect the company's governance or operations [9] - Jushen Co. signed a 1.34 billion USD bauxite transfer agreement, which is expected to positively impact future financial performance [10] - Sanxia New Materials intends to acquire a 40% stake in a subsidiary for 0 yuan, which is classified as a related party transaction [11] Group 4 - Kelun Pharmaceutical plans to repurchase shares worth 50 million to 100 million yuan for employee stock ownership plans, with a maximum price of 35 yuan per share [13] - Juxing Technology expects a net profit increase of 5.00% to 20.00% for 2025, projecting a profit of 2.419 billion to 2.764 billion yuan [15] - China National Materials Technology anticipates a net profit increase of 73.79% to 118.64% for 2025, driven by improved product structure and sales growth [16] Group 5 - Chifeng Gold forecasts a net profit increase of 70% to 81% for 2025, with gold product sales prices rising approximately 49% [17] - Dingtai High-Tech expects a net profit of 410 million to 460 million yuan for 2025, reflecting an 81% to 103% increase due to rising demand in high-end PCB markets [18] - Zhonggang Luoyang announced plans for shareholders to reduce their stakes by up to 1% of total shares [20]

再升科技（603601）(603601.SH)发布公告，近日，公司收到控股股东郭茂先生通知：因客观原因发生 变化，经郭茂先生和中融华信充分协商，一致同意解除原协议、终止本次转让。本次协议转让终止不会 导致公司控制权发生变更，不会对公司治理结构及日常生产经营造成影响，不会对公司的经营业绩及财 务状况产生不利影响，亦不存在损害公司及全体股东利益的情形。 ...

智通财经APP讯，再升科技(603601.SH)发布公告，近日，公司收到控股股东郭茂先生通知：因客观原 因发生变化，经郭茂先生和中融华信充分协商，一致同意解除原协议、终止本次转让。本次协议转让终 止不会导致公司控制权发生变更，不会对公司治理结构及日常生产经营造成影响，不会对公司的经营业 绩及财务状况产生不利影响，亦不存在损害公司及全体股东利益的情形。 ...

Group 1 - The core point of the article is that the controlling shareholder of Zai Sheng Technology, Mr. Guo Mao, signed a share transfer agreement with Zhongrong Huaxin to transfer 62,187,200 shares, representing 6.04% of the company's total share capital as of November 28, 2025, for a total price of RMB 343,895,216 [1] - The company received a notification on January 5, 2026, from Mr. Guo Mao regarding the termination of the share transfer agreement due to changes in objective circumstances, and both parties reached a consensus on this matter [1]

| 证券代码：603601 | 证券简称：再升科技 | 公告编号：临 2026-004 | | --- | --- | --- | | 债券代码：113657 | 债券简称：再 22 转债 | | 重庆再升科技股份有限公司 关于公司控股股东终止协议转让公司部分股份的公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重庆再升科技股份有限公司（以下简称：公司或再升科技）于 2026 年 1 月 5 日收到控股股东及实际控制人郭茂先生通知，获悉郭茂先生与中融华信国际生物 科技（北京）有限责任公司（以下简称：中融华信）因客观情况发生变化，就终 止协议转让公司部分股份事宜进行协商并达成一致意见。现将相关事宜公告如下： 一、本次协议转让基本情况 公司控股股东郭茂先生与中融华信于 2025 年 12 月 8 日签订了《股份转让协 议》，郭茂先生拟通过协议转让方式向中融华信转让其持有的 62,187,200 股无 限售条件流通股（占公司 11 月 28 日总股本 1,030,143,430 股的 6.04%），转让 总价款为人民 ...

| 证券代码：603601 | 证券简称：再升科技 | 公告编号：临 2026-003 | | --- | --- | --- | | 债券代码：113657 | 债券简称：再 22 转债 | | 重庆再升科技股份有限公司 可转债转股结果暨股份变动的公告 根据《上海证券交易所股票上市规则》等有关规定和《重庆再升科技股份有 限公司公开发行可转换公司债券募集说明书》（以下简称"《募集说明书》"） 的约定，本次发行的可转换公司债券转股期限自发行结束之日起满六个月后的第 累计转股情况：再 22 转债自 2023 年 4 月 12 日进入转股期，截至 2025 年 12 月 31 日，累计有 280,225,000 元再 22 转债转换为公司普通股股票，累计转 股数 66,396,791 股，占可转债转股前公司已发行股份总额的 6.50%。 未转股可转债情况：截至 2025 年 12 月 31 日，尚未转股的可转债金额为 229,773,000 元，占可转债发行总量的 45.05%。 2025 年第四季度转股情况：本季度可转债转股的金额为 244,204,000 元，因 转股形成的股份数量为 57,866,220 股。 ...

| 证券代码：603601 | 证券简称：再升科技 | 公告编号：临 2026-002 | | --- | --- | --- | | 债券代码：113657 | 债券简称：再 22 转债 | | 重庆再升科技股份有限公司 2026年第一次临时股东会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 本次会议是否有否决议案：无 一、 会议召开和出席情况 (三) 出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况： | 1、出席会议的股东和代理人人数 | 2,323 | | --- | --- | | 2、出席会议的股东所持有表决权的股份总数（股） | 356,356,616 | | 3、出席会议的股东所持有表决权股份数占公司有表决权股 | | | 份总数的比例（%） | 32.7774 | (四) 表决方式是否符合《公司法》及《公司章程》的规定，会议主持情况等。 本次股东会由董事会召集，董事长郭茂先生主持会议，会议采取现场和网络 投票相结合的表决方式进行表决。本次股东会的召集、召开程序符合《中华 ...

人民财讯1月5日电，再升科技（603601）1月5日公告，公司于2026年1月5日收到控股股东及实际控制人 郭茂通知，获悉郭茂与中融华信国际生物科技(北京)有限责任公司因客观情况发生变化，就终止协议转 让公司部分股份事宜进行协商并达成一致意见。 ...